These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24668050)

  • 1. Football for life versus antidoping for the masses: ethical antidoping issues and solutions based on the extenuating experiences of an elite footballer competing while undergoing treatment for metastatic testicular cancer.
    Weiler R; Tombides D; Urwin J; Clarke J; Verroken M
    Br J Sports Med; 2014 May; 48(10):814-6. PubMed ID: 24668050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and threats to implementing the fight against doping in sport.
    Dvorak J; Saugy M; Pitsiladis YP
    Br J Sports Med; 2014 May; 48(10):807-9. PubMed ID: 24764551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidoping Science: Important Lessons From the Medical Sciences.
    Simon P; Neuberger EW; Wang G; Pitsiladis YP
    Curr Sports Med Rep; 2018 Oct; 17(10):326-331. PubMed ID: 30300193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015.
    Dvorak J; Baume N; Botré F; Broséus J; Budgett R; Frey WO; Geyer H; Harcourt PR; Ho D; Howman D; Isola V; Lundby C; Marclay F; Peytavin A; Pipe A; Pitsiladis YP; Reichel C; Robinson N; Rodchenkov G; Saugy M; Sayegh S; Segura J; Thevis M; Vernec A; Viret M; Vouillamoz M; Zorzoli M
    Br J Sports Med; 2014 May; 48(10):801-6. PubMed ID: 24764550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethics of a relaxed antidoping rule accompanied by harm-reduction measures.
    Kayser B; Tolleneer J
    J Med Ethics; 2017 May; 43(5):282-286. PubMed ID: 28154003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juridical and ethical peculiarities in doping policy.
    McNamee MJ; Tarasti L
    J Med Ethics; 2010 Mar; 36(3):165-9. PubMed ID: 20211997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sports drug testing and the athletes' exposome.
    Thevis M; Kuuranne T; Fedoruk M; Geyer H
    Drug Test Anal; 2021 Nov; 13(11-12):1814-1821. PubMed ID: 34694748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of oral fluid in antidoping testing.
    Anizan S; Huestis MA
    Clin Chem; 2014 Feb; 60(2):307-22. PubMed ID: 24153253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A false start in the race against doping in sport: concerns with cycling's biological passport.
    Hailey N
    Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance-enhancing drugs and the Olympics.
    Watson CJ; Stone GL; Overbeek DL; Chiba T; Burns MM
    J Intern Med; 2022 Feb; 291(2):181-196. PubMed ID: 35007384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel antidoping and medical care delivery model at the 2nd Summer Youth Olympic Games (2014), Nanjing China.
    Mountjoy M; Akef N; Budgett R; Greinig S; Li G; Manikavasagam J; Soligard T; Haiming X; Yang X
    Br J Sports Med; 2015 Jul; 49(13):887-92. PubMed ID: 25833900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
    Robinson N; Sottas PE; Schumacher YO
    Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.